Similar articles

• Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.

  Madsen S. Madsen S. Acta Med Scand Suppl. 1980;638:3-120. Acta Med Scand Suppl. 1980. PMID: 6929650 No abstract available.
• The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.

  Peacock M, Davison AM, Walker GS. Peacock M, et al. Adv Exp Med Biol. 1977;81:559-69. doi: 10.1007/978-1-4613-4217-5_54. Adv Exp Med Biol. 1977. PMID: 899940 No abstract available.
• Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.

  Peacock M, Aaron JE, Walker GS, Davison AM. Peacock M, et al. Clin Endocrinol (Oxf). 1977 Dec;7 Suppl:73s-81s. doi: 10.1111/j.1365-2265.1977.tb03365.x. Clin Endocrinol (Oxf). 1977. PMID: 606428 No abstract available.
• Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.

  Massry SG, Goldstein DA, Malluche HH. Massry SG, et al. Kidney Int. 1980 Oct;18(4):409-18. doi: 10.1038/ki.1980.154. Kidney Int. 1980. PMID: 7014981 Review. No abstract available.
• Calcium metabolism in renal failure.

  David DS. David DS. Am J Med. 1975 Jan;58(1):48-56. doi: 10.1016/0002-9343(75)90532-x. Am J Med. 1975. PMID: 1090150 Review.